Abstracts Archive - Page 215 of 1683 - ATC Abstracts

2021 American Transplant Congress
Liver Transplantation in Septuagenarians
L. Egbert¹, D. Das¹, S. Ohara², J. Wagler³, G. Mahdi⁴, B. Aqel⁵, A. Moss⁵, K. S. Reddy⁵, C. Jadlowiec⁵
¹Mayo Clinic Alix School of Medicine, Scottsdale, AZ, ²Valleywise Health General Surgery Residency Program, Phoenix, AZ, ³HonorHealth John C. Lincoln, Phoenix, AZ, ⁴Mayo Clinic Alix School of Medicine, Phoenix, AZ, ⁵Mayo Clinic, Phoenix, AZ
*Purpose: The average age of liver transplant (LT) recipients has continued to increase. In spite of this, with the ongoing organ shortage, liver transplantation in…
2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Study short term outcomes of living kidney donors (LKD) who were previously infected with COVID 19, and in their recipients.*Methods: After a brief hiatus…
2021 American Transplant Congress
Combined Liver and Lung Transplantation with Extended Normothermic Liver Preservation Using Transmedics Organ Care System (OCS)^TM Liver: A Single Center Experience
J. Konel¹, M. Shamaa², O. Shamaa², A. Elsabbagh², T. Kitajima², T. Ivanics², K. Delvecchio², A. Mohamed², S. Yeddula², K. Collins², A. Yoshida², M. Abouljoud², S. Nagai², M. Rizzari²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who cannot survive single-organ transplantation alone. Ex-situ normothermic machine perfusion (NMP) has been used to increase…
2021 American Transplant Congress
Racial Differences in Tacrolimus Xr Dosing in De Novo Kidney Transplant Recipients
N. Patel, T. Carcella, F. Bartlett, V. Rohan, D. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: In May of 2020, our center was challenged with a nationwide shortage of tacrolimus IR, warranting implementation of a new de novo tacrolimus XR…
2021 American Transplant Congress
Liver Transplantation Following Checkpoint Inhibitor Therapy – Timing is Everything
G. T. Schnickel¹, J. Parekh¹, Y. Kono², J. Berumen¹, V. Ajmeera², K. Mekeel¹
¹Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego, San Diego, CA, ²Division of Gastroenterology, Department of Medicine, University of California San Diego, San Diego, CA
*Purpose: Use of checkpoint inhibitors (CPI) prior to liver transplantation has not been well studied and limited case reports describe a risk of early graft…
2021 American Transplant Congress
Covid-19 Infections Post-liver and Kidney Transplantation in a Southern Ca Program
M. E. de Vera¹, J. Woloszyn², S. Regmi², R. Rattanavich², M. Rakoski², M. Lin², P. Mehta², A. Kore², J. Weissman², C. Martens², T. Phan², B. Jerez-Aguilar², M. Robinson², E. Wells², R. Villicana², M. Nguyen²
¹Loma Linda University Health, San Bernardino, CA, ²Transplant Institute, Loma Linda University Health, San Bernardino, CA
*Purpose: Southern CA is at the epicenter of the Covid-19 pandemic. We reviewed outcomes of our center's liver, kidney, and pancreas transplant patients stricken with…
2021 American Transplant Congress
Effects of TIPS on Transplant Outcomes for HCC
C. L. Hanlon¹, D. Toy¹, Y. Liu¹, S. Zhou¹, K. Zhou², J. Kahn², L. Yuan²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²Internal Medicine - Department of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA
*Purpose: The purpose of this study is to examine effects of TIPS placement on response to locoregional therapy (LRT) and clinical outcomes after liver transplantation…
2021 American Transplant Congress
Outcomes of Robotic Living Donor Right Hepatectomy in Liver Transplant Recipients: A Systematic Review and Meta-analysis
E. Lincango-Naranjo¹, E. Garces-Delgado², P. Solis-Pazmino³, H. Alexander-Leon⁴, G. Restrepo-Rodas², R. Mancero-Montalvo², C. J. Ponce², R. Cadena-Semanate², R. Vargas-Cordova⁵, G. Herrera-Cevallos⁶, A. Villarreal-Juris⁷, S. Vallejo¹, C. Liu-Sanchez⁸, L. P. Prokop⁹, A. D. Guerron¹⁰, O. J. Ponce¹, D. Moris¹¹
¹Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, ²Universidad Internacional del Ecuador, Quito, Ecuador, ³Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA, ⁴Universidad de las Americas, Quito, Ecuador, ⁵Hospital General San Francisco IESS, Quito, Ecuador, ⁶Hospital Metropolitano, Quito, Ecuador, ⁷Universidad Central del Ecuador, Quito, Ecuador, ⁸Universidad Peruana Cayetano Heredia, Lima, Peru, ⁹Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, ¹⁰Department of Surgery, Duke University, Durham, NC, ¹¹Department of surgery, Duke University, Durham, NC
*Purpose: Living donor adult-to-adult liver transplantation (LT) has emerged as a feasible alternative to deceased donors. Advances in hepatobiliary surgery have allowed the introduction of…
2021 American Transplant Congress
Variation of Liver and Kidney Transplant Practice and Outcomes During Public Holidays in the United States
M. Shamaa, T. Kitajima, T. Ivanics, A. Elsabbagh, M. Lu, K. Delvecchio, A. Mohamed, S. Yeddula, M. Rizzari, K. Collins, A. Yoshida, M. Abouljoud, S. Nagai
Transplant surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The outcomes of liver transplant (LT) and kidney transplant (KT) have been shown to be unaffected by the time of transplant surgery whether done…
2021 American Transplant Congress
Machine Learning Informs Utility-Based Non-Directed Living Liver Donor Allocation
K. Bambha¹, J. Perkins¹, M. Sturdevant¹, S. W. Biggins¹, R. Bakthavatsalam¹, P. Healey², A. Dick², J. Reyes¹
¹University of Washington, Seattle, WA, ²Seattle Children's, Seattle, WA
*Purpose: To maximize non-directed living liver donor graft utility, we developed analytic models predicting 10-year graft survival post liver transplant (LT).*Methods: We analyzed OPTN living…